Two Australian doctors have performed a trailblazing surgery to restore the eyesight in patients who have been blind for decades – using a tooth fitted with an optical cylinder that is transplanted and stitched into […]
NHS England has announced plans for 700 more practices in England to benefit from surgery-based pharmacists following a successful pilot of the scheme. The initiative, which will impact around 6 million patients, will help to […]
Statins, but not other lipid-lowering agents, appear to protect against lower extremity amputation in patients with diabetes with known peripheral artery disease (PAD). Why this matters Patients with diabetes are at increased risk for PAD, […]
Amid warnings chronic understaffing is putting patient safety at risk, emails and texts highlight struggle to meet need. Desperate hospitals are so short of doctors they are pleading with them to take on extra shifts, […]
Findings from a new study have led to concerns about the professional behaviours of some new doctors. As part of the study, published in BJU International, authors examined the Facebook profiles of 201 urologists with publicly […]
Last month, results from a comprehensive five-year Patient Blood Management (PBM) programme in Western Australia were published in Transfusion detailing how the implementation of the programme led to reductions in hospital mortality, average hospital length […]
There are over 60 000 junior doctors working in our NHS hospitals. As young as twenty-three they are on the frontline of hospital care, from the resuscitation rooms of A&E to the operating theatres of […]
RCN members are voting on how to respond to another below-inflation pay award from the four UK Governments. Around 270,000 nursing professionals working in the NHS across the UK are eligible to take part in an […]
Researchers have found the main source of pain in Fibromyalgia patients, and contrary to what many believe, it does not stem from the brain. The findings mark the end of a decades-old mystery about the […]
The Medicines Agency of Sweden, MPA, has authorised Herantis Pharma Plc and Renishaw plc’s randomised, placebo-controlled Phase 1-2 clinical study, for the investigation of Cerebral Dopamine Neurotrophic Factor (CDNF) and Renishaw’s chronic drug delivery system, […]
Copyright © 2019 | MH Magazine WordPress Theme by MH Themes